Traws Pharma
TRAW
TRAW
23 hedge funds and large institutions have $2.19M invested in Traws Pharma in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Holders
23
Holding in Top 10
–
Calls
$22K
Puts
–
Top Buyers
| 1 | +$186K | |
| 2 | +$138K | |
| 3 | +$106K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$101K |
| 5 |
BPA
Beacon Pointe Advisors
Newport Beach,
California
|
+$18K |
Top Sellers
| 1 | -$20.7K | |
| 2 | -$14.8K | |
| 3 | -$10.6K | |
| 4 |
Jane Street
New York
|
-$7.53K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |